Y6L-12509-90104
5 vaccinations
6 coded responses
28 check-ins
5 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 581 / ND
- Registered
- 2021-03-04
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-04
Registered in v-safe
-
2021-03-04
Dose 1 — Pfizer-BioNTech
- 2021-03-04
- 2021-03-05
- 2021-03-06
- 2021-03-07
- 2021-03-08
- 2021-03-09
- 2021-03-10
- 2021-03-11
- 2021-03-18
-
2021-03-25
Dose 2 — Pfizer-BioNTech
- 2021-04-02
- 2021-04-08
- 2021-04-18
- 2021-04-22
- 2021-04-29
- 2021-05-06
- 2021-06-24
- 2021-09-25
-
2021-10-09
Dose 3 — Pfizer-BioNTech
-
2022-03-25
Survey response — 12 months, dose 2MedDRA: Nasopharyngitis, Rhinorrhoea, SARS-CoV-2 test positive, Sinus congestion — Feeling: GoodFree text: Headcold, sinus congestion and runny nose. I tested posite for Covid 19.MedDRA releases: 2024-11 · check-in free text available
-
2022-04-26
Dose 4 — Pfizer-BioNTech
-
2022-09-23
Dose 5 — Pfizer-BioNTechCo-administered: Flu
- 2022-09-27
- 2022-09-29
- 2022-10-02
- 2022-10-07
-
2022-10-14
Survey response — day 21, dose 5MedDRA: Cough, Nasopharyngitis, Paranasal sinus hypersecretion, Vertigo — Feeling: FairFree text: Cold like symptoms, sinus drainage and cough. Slight vertigo.MedDRA releases: 2024-11 · check-in free text available
-
2022-10-21
Survey response — day 28, dose 5MedDRA: Cough, Headache, Paranasal sinus hypersecretion — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Sinus drainage and coughing till my head hurts.MedDRA releases: 2024-11 · check-in free text available
-
2022-10-28
Survey response — day 35, dose 5MedDRA: Paranasal sinus hypersecretion, Productive cough, Upper respiratory tract infection — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Relentless upper respiratory infection that is not reaponding to antibiotics. Sinus drainage and productive cough. Lungs are fine.MedDRA releases: 2024-11 · check-in free text available
-
2022-10-28
Report sent to call center — day 35, dose 5Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-10-31
-
2022-10-31
Callback requested for06:14PM ET
-
2022-10-31
Call successfulParticipant prefers to complete VAERS report online
-
2022-11-05
Survey response — day 42, dose 5MedDRA: Cough, Paranasal sinus hypersecretion — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Continued sinus drainage and coughing. I have started taking allergy medication and symptoms have lessened.MedDRA releases: 2024-11 · check-in free text available
- 2022-12-25
-
2023-03-25
Survey response — 6 months, dose 5MedDRA: Nasopharyngitis, SARS-CoV-2 test negative — Feeling: GoodMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-04 | Pfizer-BioNTech | |
| 2 | 2021-03-25 | Pfizer-BioNTech | |
| 3 | 2021-10-09 | Pfizer-BioNTech | No |
| 4 | 2022-04-26 | Pfizer-BioNTech | No |
| 5 | 2022-09-23 | Pfizer-BioNTech | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-10-28 | Successful 2022-10-31 |
Participant prefers to complete VAERS report online |
Free text
Release 11 — 12 months, dose 2
Symptoms: Headcold, sinus congestion and runny nose. I tested posite for Covid 19.
Release 12 — day 21, dose 5
Symptoms: Cold like symptoms, sinus drainage and cough. Slight vertigo.
Release 12 — day 28, dose 5
Symptoms: Sinus drainage and coughing till my head hurts.
Release 12 — day 35, dose 5
Symptoms: Relentless upper respiratory infection that is not reaponding to antibiotics. Sinus drainage and productive cough. Lungs are fine.
Release 12 — day 42, dose 5
Symptoms: Continued sinus drainage and coughing. I have started taking allergy medication and symptoms have lessened.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Paranasal sinus hypersecretion | · | · | ✓ |
| SD | Productive cough | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SD | Sinus congestion | · | · | ✓ |
| SD | Upper respiratory tract infection | · | · | ✓ |
| SD | Vertigo | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release